Tetrahedral Framework Nucleic Acids-based Delivery of MicroRNA-22 Inhibits Pathological Neovascularization and Vaso-obliteration by Regulating the Wnt Pathway

Overview

Journal Cell Prolif

Date 2024 Mar 4

PMID 38433462

Authors

Xinyu Liu

Xiaoxiao Xu

Yanting Lai

Xiaodi Zhou

Limei Chen

Qiong Wang

Yili Jin

Delun Luo

Xiaoyan Ding

Affiliations

Soon will be listed here.

Abstract

The objective of this study was to investigate the effects and molecular mechanisms of tetrahedral framework nucleic acids-microRNA22 (tFNAs-miR22) on inhibiting pathological retinal neovascularization (RNV) and restoring physiological retinal vessels. A novel DNA nanocomplex (tFNAs-miR22) was synthesised by modifying microRNA-22 (miR22) through attachment onto tetrahedral frame nucleic acids (tFNAs), which possess diverse biological functions. Cell proliferation, wound healing, and tube formation were employed for in vitro assays to investigate the angiogenic function of cells. Oxygen-induced retinopathy (OIR) model was utilised to examine the effects of reducing pathological neovascularization (RNV) and inhibiting vascular occlusion in vivo. In vitro, tFNAs-miR22 demonstrated the ability to penetrate endothelial cells and effectively suppress cell proliferation, tube formation, and migration in a hypoxic environment. In vivo, tFNAs-miR22 exhibited promising results in reducing RNV and promoting the restoration of normal retinal blood vessels in OIR model through modulation of the Wnt pathway. This study provided a theoretical basis for the further understanding of RNV, and highlighted the innovative and potential of tFNAs-miR22 as a therapeutic option for ischemic retinal diseases.

Citing Articles

Tetrahedral framework nucleic acids-based delivery of MicroRNA-22 inhibits pathological neovascularization and vaso-obliteration by regulating the Wnt pathway.

Liu X, Xu X, Lai Y, Zhou X, Chen L, Wang Q Cell Prolif. 2024; 57(7):e13623.

PMID: 38433462 PMC: 11216936. DOI: 10.1111/cpr.13623.

References

Lu H, Wang B . SIRT1 exerts neuroprotective effects by attenuating cerebral ischemia/reperfusion-induced injury via targeting p53/microRNA-22. Int J Mol Med. 2016; 39(1):208-216. DOI: 10.3892/ijmm.2016.2806. View

Wang Y, Li Y, Gao S, Yu X, Chen Y, Lin Y . Tetrahedral Framework Nucleic Acids Can Alleviate Taurocholate-Induced Severe Acute Pancreatitis and Its Subsequent Multiorgan Injury in Mice. Nano Lett. 2022; 22(4):1759-1768. DOI: 10.1021/acs.nanolett.1c05003. View

Wang S, Park J, Duh E . Novel targets against retinal angiogenesis in diabetic retinopathy. Curr Diab Rep. 2012; 12(4):355-63. DOI: 10.1007/s11892-012-0289-0. View

Wong T, Scott I . Clinical practice. Retinal-vein occlusion. N Engl J Med. 2010; 363(22):2135-44. DOI: 10.1056/NEJMcp1003934. View

Richter M, Gottanka J, May C, Welge-Lussen U, Berger W, Lutjen-Drecoll E . Retinal vasculature changes in Norrie disease mice. Invest Ophthalmol Vis Sci. 1998; 39(12):2450-7. View

Semeraro F, Parrinello G, Cancarini A, Pasquini L, Zarra E, Cimino A . Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabetes Complications. 2011; 25(5):292-7. DOI: 10.1016/j.jdiacomp.2010.12.002. View

Chan-Ling T, Gole G, Quinn G, Adamson S, Darlow B . Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective. Prog Retin Eye Res. 2017; 62:77-119. DOI: 10.1016/j.preteyeres.2017.09.002. View

Hayreh S . Photocoagulation for retinal vein occlusion. Prog Retin Eye Res. 2021; 85:100964. DOI: 10.1016/j.preteyeres.2021.100964. View

Sapieha P, Joyal J, Rivera J, Kermorvant-Duchemin E, Sennlaub F, Hardy P . Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest. 2010; 120(9):3022-32. PMC: 2929716. DOI: 10.1172/JCI42142. View

10.

Vujosevic S, Aldington S, Silva P, Hernandez C, Scanlon P, Peto T . Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020; 8(4):337-347. DOI: 10.1016/S2213-8587(19)30411-5. View

11.

Ohlmann A, Scholz M, Goldwich A, Chauhan B, Hudl K, Ohlmann A . Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice. J Neurosci. 2005; 25(7):1701-10. PMC: 6725931. DOI: 10.1523/JNEUROSCI.4756-04.2005. View

12.

Sherris D . Ocular drug development--future directions. Angiogenesis. 2007; 10(2):71-6. DOI: 10.1007/s10456-007-9068-y. View

13.

Liu X, Xu X, Lai Y, Zhou X, Chen L, Wang Q . Tetrahedral framework nucleic acids-based delivery of MicroRNA-22 inhibits pathological neovascularization and vaso-obliteration by regulating the Wnt pathway. Cell Prolif. 2024; 57(7):e13623. PMC: 11216936. DOI: 10.1111/cpr.13623. View

14.

Chen R, Wen D, Fu W, Xing L, Ma L, Liu Y . Treatment effect of DNA framework nucleic acids on diffuse microvascular endothelial cell injury after subarachnoid hemorrhage. Cell Prolif. 2022; 55(4):e13206. PMC: 9055902. DOI: 10.1111/cpr.13206. View

15.

Rehm H, Zhang D, Christian Brown M, Burgess B, Halpin C, Berger W . Vascular defects and sensorineural deafness in a mouse model of Norrie disease. J Neurosci. 2002; 22(11):4286-92. PMC: 6758776. DOI: 2002. View

16.

Mechoulam H, Pierce E . Retinopathy of prematurity: molecular pathology and therapeutic strategies. Am J Pharmacogenomics. 2003; 3(4):261-77. DOI: 10.2165/00129785-200303040-00004. View

17.

Nakamura M, Hayashi M, Konishi H, Nunode M, Ashihara K, Sasaki H . MicroRNA-22 enhances radiosensitivity in cervical cancer cell lines via direct inhibition of c-Myc binding protein, and the subsequent reduction in hTERT expression. Oncol Lett. 2020; 19(3):2213-2222. PMC: 7038919. DOI: 10.3892/ol.2020.11344. View

18.

Shi S, Li Y, Zhang T, Xiao D, Tian T, Chen T . Biological Effect of Differently Sized Tetrahedral Framework Nucleic Acids: Endocytosis, Proliferation, Migration, and Biodistribution. ACS Appl Mater Interfaces. 2021; 13(48):57067-57074. DOI: 10.1021/acsami.1c20657. View

19.

Linsenmeier R, Zhang H . Retinal oxygen: from animals to humans. Prog Retin Eye Res. 2017; 58:115-151. PMC: 5441959. DOI: 10.1016/j.preteyeres.2017.01.003. View

20.

Zhang T, Tian T, Lin Y . Functionalizing Framework Nucleic-Acid-Based Nanostructures for Biomedical Application. Adv Mater. 2021; 34(46):e2107820. DOI: 10.1002/adma.202107820. View